50
Participants
Start Date
October 31, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
Trans-resveratrol
In this crossoevr study, all participants also consumed 500mg trans-resveratrol (in 2 opaque vegetarian capsules), at baseline, on counterballanced days.
Placebo
In this crossoevr study, all participants also consumed placebo (2 opaque vegetarian capsules), at baseline, on counterballanced days.
Brain performance and nutrition research centre, Northumbria university, Newcastle upon Tyne
Northumbria University
OTHER